Secondary Analysis and Integration of Existing Data to Elucidate Cancer Risk and Related Outcomes (R21 Clinical Trials Not Allowed)
Open Posted
- Opportunity number
- PAR-25-096
- Agency
-
National Institutes of Health
Department of Health and Human Services
- Applications due
- Award size
- Up to $200,000
Opportunity facts
- Assistance listings
-
- 93.866 Aging Research
- 93.172 Human Genome Research
- 93.393 Cancer Cause and Prevention Research
- 93.121 Oral Diseases and Disorders Research
- Funding instrument
- Grant
- Categories
-
- Education
- Health
- Eligible applicants
-
- Higher Education Inst. (Public)
- County Governments
- For Profit Organizations
- Independent School Districts
- Non-501(c)(3) Nonprofits
- Public or Indian Housing Auth.
- Small Businesses
- Higher Education Inst. (Private)
- Special District Governments
- State Governments
- Other
- Tribal Organizations (Not Federally Recognized)
- 501(c)(3) Nonprofits
- Tribal Governments (Federally Recognized)
- City/Township Governments
- Points of contact
-
- NIH OER Webmaster grantsinfo@nih.gov
- Full announcement
Opportunity details come from Grants.gov. Updated .
About this opportunity
The National Cancer Institute (NCI) along with other participating NIH Institutes is soliciting applications for secondary analysis and integration of existing datasets to elucidate cancer risk and related outcomes, with an application due date of November 17, 2026.
Eligible applicants include higher education institutions (public and private), county governments, for-profit organizations, independent school districts, non-501(c)(3) nonprofits, public or Indian housing authorities, small businesses, special district governments, state governments, tribal organizations (both federally and non-federally recognized), 501(c)(3) nonprofits, city and township governments, and other entities including HBCUs, Hispanic-serving institutions, Asian American Native American Pacific Islander Serving Institutions, tribally controlled colleges and universities, faith-based or community-based organizations, and non-domestic entities.
The initiative funds secondary data analysis and integration of existing clinical, environmental, surveillance, health services, vital statistics, behavioral, lifestyle, genomic, and molecular profiles data. Applicants are encouraged to leverage and perform innovative analyses of existing data, including new research aims addressed with existing data, new or advanced methods of analyses, or novel combinations and integration of datasets that explore important scientific questions in cancer research.
This opportunity is associated with four federal grant programs: Cancer Cause and Prevention Research (CFDA 93.393), Oral Diseases and Disorders Research (CFDA 93.121), Human Genome Research (CFDA 93.172), and Aging Research (CFDA 93.866). The R21 mechanism is used; clinical trials are not allowed. Award details including ceiling, expected number of awards, period of performance, evaluation criteria, and cost-share requirements are not specified in the source material.
Synopsis
Through this Notice of Funding Opportunity (NOFO), the National Cancer Institute (NCI) along with other participating Institutes encourages submission of applications proposing to conduct secondary data analysis and integration of existing datasets and database resources, with the ultimate aim to elucidate cancer risk and related outcomes (e.g., risk prediction or reduction, survival, or response to treatment, etc.). The goal of this initiative is to address key scientific questions relevant to cancer by supporting the analysis of existing clinical, environmental, surveillance, health services, vital statistics, behavioral, lifestyle, genomic, and molecular profiles data. Applicants are encouraged to leverage and perform innovative analyses of the existing data. Applications may include new research aims that are being addressed with existing data, new or advanced methods of analyses, or novel combinations and integration of datasets that allow the exploration of important scientific questions in cancer research.
Eligibility
Other Eligible Applicants include the following: Alaska Native and Native Hawaiian Serving Institutions; Asian American Native American Pacific Islander Serving Institutions (AANAPISISs); Eligible Agencies of the Federal Government; Faith-based or Community-based Organizations; Hispanic-serving Institutions; Historically Black Colleges and Universities (HBCUs); Indian/Native American Tribal Governments (Other than Federally Recognized); Non-domestic (non-U.S.) Entities (Foreign Organizations); Regional Organizations; Tribally Controlled Colleges and Universities (TCCUs) ; U.S. Territory or Possession.
Files
| File | Type | Posted |
|---|---|---|
| PAR-25-096-Full-Announcement.html | HTML file | |
| PKG00288794.pdf |
On GovTribe
Work this opportunity
- Track it in your pipeline
- Find teaming partners
- Similar grant opportunities
- Ask GovTribe AI about this opportunity